A detailed history of Kistler Tiffany Companies, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kistler Tiffany Companies, LLC holds 2,283 shares of LLY stock, worth $1.8 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,283
Previous 1,968 16.01%
Holding current value
$1.8 Million
Previous $675,000 58.52%
% of portfolio
0.17%
Previous 0.13%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023

BUY
$350.74 - $468.98 $110,483 - $147,728
315 Added 16.01%
2,283 $1.07 Million
Q1 2023

May 03, 2023

SELL
$310.63 - $364.82 $74,861 - $87,921
-241 Reduced 10.91%
1,968 $675,000
Q4 2022

Jan 27, 2023

SELL
$321.55 - $374.67 $167,849 - $195,577
-522 Reduced 19.11%
2,209 $808,000
Q2 2022

Aug 08, 2022

BUY
$278.73 - $327.27 $26,200 - $30,763
94 Added 3.56%
2,731 $885,000
Q1 2022

May 11, 2022

BUY
$234.69 - $291.66 $180,241 - $223,994
768 Added 41.09%
2,637 $755,000
Q4 2021

Jan 25, 2022

BUY
$224.85 - $279.04 $133,336 - $165,470
593 Added 46.47%
1,869 $516,000
Q1 2021

May 07, 2021

SELL
$164.32 - $212.72 $1,150 - $1,489
-7 Reduced 0.55%
1,276 $238,000
Q4 2020

Feb 03, 2021

BUY
$130.46 - $172.63 $19,569 - $25,894
150 Added 13.24%
1,283 $217,000
Q2 2020

Jul 20, 2020

BUY
$136.42 - $164.18 $95,630 - $115,090
701 Added 162.27%
1,133 $186,000
Q4 2019

Jan 14, 2020

SELL
$106.92 - $132.43 $32,076 - $39,729
-300 Reduced 40.98%
432 $57,000
Q3 2018

Oct 19, 2018

SELL
$85.86 - $107.31 $1,631 - $2,038
-19 Reduced 2.53%
732 $79,000
Q2 2018

Jul 17, 2018

BUY
$75.7 - $86.88 $1,438 - $1,650
19 Added 2.6%
751 $64,000
Q1 2018

Apr 06, 2018

BUY
$74.21 - $87.6 $51,946 - $61,319
700 Added 2187.5%
732 $57,000
Q3 2017

Oct 19, 2017

BUY
$77.07 - $85.54 $2,466 - $2,737
32
32 $3,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kistler Tiffany Companies, LLC Portfolio

Follow Kistler Tiffany Companies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kistler Tiffany Companies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kistler Tiffany Companies, LLC with notifications on news.